JNJ
Johnson & Johnson
Drug Manufacturers - General · Healthcare · United States
262.08
close · 2026-08-13
value
30
cheaper than peers30
quality
80
stronger fundamentals80
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 21.29× | 41 |
| EV to EBITDA | 19.24× | 40 |
| price to sales | 6.53× | 35 |
| price to book | 7.43× | 31 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 29.2% | 92 |
| return on equity | 25.7% | 89 |
| debt to equity | 57.7% | 41 |
| revenue growth | 6.6% | 38 |
4 of 4 measures available
Facts
| market cap | $632B |
| free cash flow | $16.89B |
| employees | 138,200 |
| first trade | 1962-01-02 |
| next earnings | 2026-10-13 |
| fundamentals updated | 2026-07-29 |